+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Infectious Disease Diagnostic Market Research Report by Product, Technology, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 221 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 4829907
UP TO OFF until Dec 31st 2022
The Global Infectious Disease Diagnostic Market size was estimated at USD 21.40 billion in 2021, USD 22.79 billion in 2022, and is projected to grow at a CAGR of 6.68% to reach USD 31.54 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Infectious Disease Diagnostic to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Instruments, Reagents, and Software & Services.
  • Based on Technology, the market was studied across Biochemical Technology, Conventional Technology, and Molecular Technology.
  • Based on Application, the market was studied across Bacterial Infection, Cardiovascular Infection, CNS Infection, Fungal Infection, Sexually Transmitted Disease, and Viral Infection.
  • Based on End User, the market was studied across Hospital and Research Institutes.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Infectious Disease Diagnostic market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Infectious Disease Diagnostic Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Infectious Disease Diagnostic Market, including Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories,Inc, BioFire Diagnostics, Biomérieux SA, Co-Diagnostics, Inc., Danaher Corporation, DiaSorin, HiberGene Diagnostics Limited, Luminex Corporation, Meridian Bioscience Inc., Quidel Corporation, Roche Holding AG, Siemens AG, and Thermo Fisher Scientific.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Infectious Disease Diagnostic Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Infectious Disease Diagnostic Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Infectious Disease Diagnostic Market?
4. What is the competitive strategic window for opportunities in the Global Infectious Disease Diagnostic Market?
5. What are the technology trends and regulatory frameworks in the Global Infectious Disease Diagnostic Market?
6. What is the market share of the leading vendors in the Global Infectious Disease Diagnostic Market?
7. What modes and strategic moves are considered suitable for entering the Global Infectious Disease Diagnostic Market?
Frequently Asked Questions about the Global Infectious Disease Diagnostic Market

What is the estimated value of the Global Infectious Disease Diagnostic Market?

The Global Infectious Disease Diagnostic Market was estimated to be valued at $21.4 Billion in 2021.

What is the growth rate of the Global Infectious Disease Diagnostic Market?

The growth rate of the Global Infectious Disease Diagnostic Market is 6.6%, with an estimated value of $31.54 Billion by 2027.

What is the forecasted size of the Global Infectious Disease Diagnostic Market?

The Global Infectious Disease Diagnostic Market is estimated to be worth $31.54 Billion by 2027.

Who are the key companies in the Global Infectious Disease Diagnostic Market?

Key companies in the Global Infectious Disease Diagnostic Market include Abbott Laboratories, Becton, Dickinson and Company, Bio, Rad Laboratories ,Inc, BioFire Diagnostics, Biomérieux SA, Co, Diagnostics, Inc. and DiaSorin.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing global prevalence and periodic outbreak of infectious diseases
5.1.1.2. Shift in focus towards decentralized point-of-care testing from centralized laboratories
5.1.1.3. Increasing funding for research on infectious disease diagnostics
5.1.2. Restraints
5.1.2.1. Inadequate reimbursements
5.1.2.2. Rising healthcare costs limiting the use of novel diagnostic techniques
5.1.3. Opportunities
5.1.3.1. Advancements in genomics and proteomics
5.1.3.2. Increasing awareness about personalized medicine
5.1.3.3. Growth opportunities in emerging markets
5.1.4. Challenges
5.1.4.1. Limited transparency and improper handling of samples
5.2. Cumulative Impact of COVID-19
6. Infectious Disease Diagnostic Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents
6.4. Software & Services
7. Infectious Disease Diagnostic Market, by Technology
7.1. Introduction
7.2. Biochemical Technology
7.3. Conventional Technology
7.4. Molecular Technology
8. Infectious Disease Diagnostic Market, by Application
8.1. Introduction
8.2. Bacterial Infection
8.3. Cardiovascular Infection
8.4. CNS Infection
8.5. Fungal Infection
8.6. Sexually Transmitted Disease
8.7. Viral Infection
9. Infectious Disease Diagnostic Market, by End User
9.1. Introduction
9.2. Hospital
9.3. Research Institutes
10. Americas Infectious Disease Diagnostic Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Infectious Disease Diagnostic Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Infectious Disease Diagnostic Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbott Laboratories
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Becton, Dickinson and Company
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Bio-Rad Laboratories ,Inc
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. BioFire Diagnostics
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Biomérieux SA
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Co-Diagnostics, Inc.
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Danaher Corporation
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. DiaSorin
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. HiberGene Diagnostics Limited
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Luminex Corporation
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Meridian Bioscience Inc.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Quidel Corporation
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Roche Holding AG
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Siemens AG
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Thermo Fisher Scientific
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 4. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET DYNAMICS
FIGURE 11. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 12. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2027
FIGURE 14. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2027 (USD BILLION)
FIGURE 15. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2027 (USD BILLION)
FIGURE 17. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 18. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2027
FIGURE 20. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BIOCHEMICAL TECHNOLOGY, 2018-2027 (USD BILLION)
FIGURE 21. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL TECHNOLOGY, 2018-2027 (USD BILLION)
FIGURE 22. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MOLECULAR TECHNOLOGY, 2018-2027 (USD BILLION)
FIGURE 23. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 24. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
FIGURE 25. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
FIGURE 26. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTION, 2018-2027 (USD BILLION)
FIGURE 27. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CARDIOVASCULAR INFECTION, 2018-2027 (USD BILLION)
FIGURE 28. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CNS INFECTION, 2018-2027 (USD BILLION)
FIGURE 29. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTION, 2018-2027 (USD BILLION)
FIGURE 30. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE, 2018-2027 (USD BILLION)
FIGURE 31. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTION, 2018-2027 (USD BILLION)
FIGURE 32. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 33. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
FIGURE 34. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 35. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITAL, 2018-2027 (USD BILLION)
FIGURE 36. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2027 (USD BILLION)
FIGURE 37. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 38. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 39. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 40. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 41. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 42. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 43. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 44. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 45. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 46. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 47. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 48. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 49. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 50. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 51. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 52. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 53. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 54. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 55. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 57. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 58. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 59. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 60. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 61. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 68. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 69. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 70. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 71. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 72. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 73. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 74. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 75. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 76. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 77. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 78. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 79. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 80. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 81. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 82. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 83. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 84. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 85. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 86. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 87. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 88. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 89. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 90. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 91. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 92. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY REAGENTS, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BIOCHEMICAL TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 18. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BIOCHEMICAL TECHNOLOGY, BY REGION, 2018-2027 (USD BILLION)
TABLE 19. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BIOCHEMICAL TECHNOLOGY, BY REGION, 2018-2027 (USD BILLION)
TABLE 20. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 21. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL TECHNOLOGY, BY REGION, 2018-2027 (USD BILLION)
TABLE 22. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CONVENTIONAL TECHNOLOGY, BY REGION, 2018-2027 (USD BILLION)
TABLE 23. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MOLECULAR TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 24. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MOLECULAR TECHNOLOGY, BY REGION, 2018-2027 (USD BILLION)
TABLE 25. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY MOLECULAR TECHNOLOGY, BY REGION, 2018-2027 (USD BILLION)
TABLE 26. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 27. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTION, 2018-2027 (USD BILLION)
TABLE 28. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTION, BY REGION, 2018-2027 (USD BILLION)
TABLE 29. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY BACTERIAL INFECTION, BY REGION, 2018-2027 (USD BILLION)
TABLE 30. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CARDIOVASCULAR INFECTION, 2018-2027 (USD BILLION)
TABLE 31. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CARDIOVASCULAR INFECTION, BY REGION, 2018-2027 (USD BILLION)
TABLE 32. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CARDIOVASCULAR INFECTION, BY REGION, 2018-2027 (USD BILLION)
TABLE 33. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CNS INFECTION, 2018-2027 (USD BILLION)
TABLE 34. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CNS INFECTION, BY REGION, 2018-2027 (USD BILLION)
TABLE 35. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY CNS INFECTION, BY REGION, 2018-2027 (USD BILLION)
TABLE 36. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTION, 2018-2027 (USD BILLION)
TABLE 37. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTION, BY REGION, 2018-2027 (USD BILLION)
TABLE 38. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY FUNGAL INFECTION, BY REGION, 2018-2027 (USD BILLION)
TABLE 39. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE, 2018-2027 (USD BILLION)
TABLE 40. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE, BY REGION, 2018-2027 (USD BILLION)
TABLE 41. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE, BY REGION, 2018-2027 (USD BILLION)
TABLE 42. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTION, 2018-2027 (USD BILLION)
TABLE 43. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTION, BY REGION, 2018-2027 (USD BILLION)
TABLE 44. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY VIRAL INFECTION, BY REGION, 2018-2027 (USD BILLION)
TABLE 45. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 46. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITAL, 2018-2027 (USD BILLION)
TABLE 47. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 48. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2027 (USD BILLION)
TABLE 49. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2027 (USD BILLION)
TABLE 50. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2027 (USD BILLION)
TABLE 51. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2027 (USD BILLION)
TABLE 52. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 53. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 54. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 55. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 56. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 57. AMERICAS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 58. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 59. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 60. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 61. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 62. ARGENTINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 63. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 64. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 65. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 66. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 67. BRAZIL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 68. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 69. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 70. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 71. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 72. CANADA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 73. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 74. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 75. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 76. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 77. MEXICO INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 78. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 79. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2027 (USD BILLION)
TABLE 80. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 81. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 82. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 83. UNITED STATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 84. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 85. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 86. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 87. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 88. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 89. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 90. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 91. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 92. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 93. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 94. AUSTRALIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 95. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 96. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 97. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 98. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 99. CHINA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 100. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 101. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 102. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 103. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 104. INDIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 105. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 106. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 107. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 108. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 109. INDONESIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 110. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 111. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 112. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 113. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 114. JAPAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 115. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 116. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 117. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 118. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 119. MALAYSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 120. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 121. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 122. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 123. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 124. PHILIPPINES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 125. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 126. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 127. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 128. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 129. SINGAPORE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 130. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 131. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 132. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 133. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 134. SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 135. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 136. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 137. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 138. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 139. TAIWAN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 140. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 141. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 142. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 143. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 144. THAILAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 145. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 146. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 147. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 148. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 149. VIETNAM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2027 (USD BILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 156. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 157. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 158. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 159. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 160. DENMARK INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 161. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 162. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 163. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 164. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 165. EGYPT INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 166. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 167. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 168. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 169. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 170. FINLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 171. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 172. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 173. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 174. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 175. FRANCE INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 176. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 177. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 178. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 179. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 180. GERMANY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 181. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 182. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 183. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 184. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 185. ISRAEL INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 186. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 187. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 188. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 189. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 190. ITALY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 191. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 192. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 193. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 194. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 195. NETHERLANDS INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 196. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 197. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 198. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 199. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 200. NIGERIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 201. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 202. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 203. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 204. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 205. NORWAY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 206. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 207. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 208. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 209. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 210. POLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 211. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 212. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 213. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 214. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 215. QATAR INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 216. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 217. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 218. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 219. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 220. RUSSIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 221. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 222. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 223. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 224. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 225. SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 226. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 227. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 228. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 229. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 230. SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 231. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 232. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 233. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 234. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 235. SPAIN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 236. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 237. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 238. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 239. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 240. SWEDEN INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 241. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 242. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 243. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 244. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 245. SWITZERLAND INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 246. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 247. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 248. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 249. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 250. TURKEY INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 251. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 252. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 253. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 254. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 255. UNITED ARAB EMIRATES INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 256. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 257. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2027 (USD BILLION)
TABLE 258. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 259. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 260. UNITED KINGDOM INFECTIOUS DISEASE DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 261. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 262. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 263. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 264. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET RANKING, BY KEY PLAYER, 2021
TABLE 265. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2021
TABLE 266. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET MERGER & ACQUISITION
TABLE 267. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 268. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 269. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET INVESTMENT & FUNDING
TABLE 270. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 271. GLOBAL INFECTIOUS DISEASE DIAGNOSTIC MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories ,Inc
  • BioFire Diagnostics
  • Biomérieux SA
  • Co-Diagnostics, Inc.
  • Danaher Corporation
  • DiaSorin
  • HiberGene Diagnostics Limited
  • Luminex Corporation
  • Meridian Bioscience Inc.
  • Quidel Corporation
  • Roche Holding AG
  • Siemens AG
  • Thermo Fisher Scientific

Methodology

Loading
LOADING...